Elevate Minoxidil liquid

Manufacturer
GUANGZHOU NODA PHARMACEUTICAL TECHNOLOGY INCORPORATED CO., LTD
Effective date
2023-10-11
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-01 21:24:40

Label at a glance#

ProductElevate Minoxidil liquid
Active ingredientMINOXIDIL
Label structure15 sections

Storage and handling

Store at controlled room temperature 20° to 25°C (68° to 77°F)

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Minoxidil 2%

OTC - PURPOSE SECTION

Hair regrowth treatment

INACTIVE INGREDIENT SECTION

Deionized Water,

Propylen Glycol, Alcohol,

Panax Ginseng, Pro-Vitamin B5.

DOSAGE & ADMINISTRATION SECTION

Spray 1ml (5 sprays) twice a day. Once in the morning and another time in the evening before bed. Use only on fully dry hair. Spray directly on top of the scalp of hair loss area. Results can vary and take time but we recommend at least 3-5 months of usage.

OTC - DO NOT USE SECTION

Do not use if

you are under 18 years of age. Do not use on babies and children.

your scalp is red, inflamed, infected, irritated, or painful

you use other medicines on the scalp

When using this product

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have heart disease

WARNINGS SECTION

For external use only. For use on scalp only. Avoid contact with eyes.

May be harmful if used when pregnant or breast-feeding.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away.

STORAGE AND HANDLING SECTION

Store at controlled room temperature 20° to 25°C (68° to 77°F)

ALARMS

WHAT SIDE EFFECTS CAN OCCUR?

Minoxidil may cause side effects.

Discontinue use immediately or tell

your doctor if any of these symptoms

are severe or do not go away: scalp

itching, dryness, scaling, flaking,

irritation, or burning.

OTC - STOP USE SECTION

Stop use and ask a doctor if

Chest pain, rapid heartbeat, faintness, or dizziness occurs

sudden, unexplained weight gain occurs

Your hands or feet swell

Scalp irritation or redness occurs

Unwanted facial hair growth occurs

You do not see hair regrowth in 4 months

OTC - WHEN USING SECTION

When using this product

Do not apply on other parts of the body.

Avoid contact with the eyes. In case of accidental contact, rinse eyes with large amounts of cool tap water.

Some people have experienced changes in hair color and/or texture

It takes time to regrow hair. You may need to use this product 2 times a day for at least 4 months before you see results.

The amount of hair regrowth is different for each person. This product will not work for everyone.

DESCRIPTION SECTION

ELEVATE 2% MINOXIDIL

is applied to the scalp and used to

stimulate hair growth in adult women.

It’s a spray solution to treat hair loss

and help regrow hair.

INDICATIONS & USAGE SECTION

Prevent and Stop Hair Loss

• Stimulate Hair Growth

• Improve Fullness of Hair

• Restore Vitality of Hair

• Strengthen and Activate Hair Follicles

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DS467DS467

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
78098-30578098-305-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
0e7b7508-03b0-2f70-e063-6294a90acdeafd0cc35d-c144-6d83-e053-6394a90afb6b2024-01-08WarningsExact identifier
spl set id: fd0cc35d-c144-6d83-e053-6394a90afb6b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.